Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,510.70 +129.66 0.84%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,187.90 +7.84 0.15%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Therapeutics

Anika Therapeutics Inc

+ Add to Watchlist

ANIK:US

14.4500 USD 0.0600 0.42%

As of 20:10:00 ET on 05/21/2013.

Company Profile for Anika Therapeutics Inc (ANIK)

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Contact Information

Anika Therapeutics Inc

32 Wiggins Avenue
Bedford, MA 01730
United States
Phone: 1-781-457-9000
Fax: 1-781-305-9720

Key Executives for Anika Therapeutics Inc (ANIK)

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Frank J LuppinoChief Operating Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil